We manage your entire project pipeline from initial spheroid formation and matrix optimization through to pilot screening and large-scale high-throughput validation stages.
Creative Biolabs provides researchers with a sophisticated platform to evaluate the invasive potential of cell models in a controlled, three-dimensional environment. We provide high-resolution kinetic imaging, standardized extracellular matrices, and quantitative analysis of cellular movement. By partnering with us, clients gain access to actionable data regarding compound efficacy against metastatic phenotypes, clearer insights into cellular interactions within the microenvironment, and a reliable method for benchmarking lead candidates before moving to more complex models.
Metastasis remains a major challenge in oncology research, yet drug discovery is often hampered by the lack of predictive models. Literature suggests that 3D spheroid models more effectively recreate the epithelial-to-mesenchymal transition (EMT) and hypoxic signaling compared to 2D monolayers. By incorporating standardized oligomeric matrices and co-cultures, Creative Biolabs' platform provides a high-fidelity surrogate for the tissue microenvironment, enabling the quantification of collective cell migration and matrix remodeling with research-grade precision.
Fig.1 Overview of 3D tumor-tissue invasion model and fabrication system. 1
We manage your entire project pipeline from initial spheroid formation and matrix optimization through to pilot screening and large-scale high-throughput validation stages.
Our team integrates specialized cell types like CAFs, immune cells, or endothelial cells into your models to accurately mimic complex tumor-stroma interactions.
Utilize our automated 96-well and 384-well platforms to perform efficient, simultaneous analysis of various compound concentrations across extensive drug libraries.
We apply rigorous quality-by-design and process analytical techniques to matrix polymerization and spheroid uniformity, ensuring the highest level of data reproducibility.
Creative Biolabs operates at the precise intersection of bioengineering and high-throughput screening to deliver robust, data-driven insights for your most complex oncology research projects.
We utilize specialized Oligomeric Type I Collagen to preserve natural intermolecular crosslinks, providing a superior physiological model for stiff and desmoplastic tumor environments.
Our platform utilizes 3D-printed guides to eliminate manual embedding variability, ensuring every well in a 96-well plate is an exact, high-quality replica.
This technical rigor produces consistent, high-quality results and visual data that are perfectly prepared for your internal reviews, project milestones, or upcoming publications.
Get a quote today to leverage our high-fidelity 3D platforms for your next discovery milestone.
Absolutely. We have experience in adapting proprietary models into our standardized 96-well format, ensuring your specific samples are preserved in a biomimetic state.
Oligomeric collagen preserves the natural crosslinks found in tissue, making it more resistant to rapid degradation and providing a more realistic mechanical barrier.
Evaluate the ability of aggressive tumor cells to form vessel-like structures, providing insights into non-endothelial tumor vascularization mechanisms.
Learn More →Access our library of verified cell lines to evaluate drug responses across diverse genetic backgrounds and specific cancer subtypes.
Learn More →Creative Biolabs provides a high-quality 3D spheroid/organoid invasion assay service that combines bioengineered precision with high-content kinetic analytics. By utilizing standardized oligomeric collagen and automated 3D imaging, we deliver predictive data that supports early-stage research and compound validation.
Ready to elevate your research? Our specialists are available to design a customized study that fits your specific goals - Contact us.
Reference